BAG3基因突变所致扩张型心肌病的表型与预后
本研究在18个欧洲中心纳入129例BAG3突变携带者,中位随访38个月,发现40岁以上携带者疾病外显率达80%,扩张型心肌病(DCM)患者年不良心脏事件发生率为5.1%,男性、左室射血分数降低和左室舒张末内径增大与不良事件相关。
要点
- 40岁以上BAG3突变携带者疾病外显率高达80%。
- 合并DCM的BAG3突变者年不良心脏事件发生率为5.1%。
- 男性、左室射血分数降低和左室舒张末内径增大提示预后不良。
核心结论
- BAG3突变所致DCM在40岁以上携带者中外显率高,进展性心力衰竭风险高。
- 男性、左室射血分数降低和左室舒张末内径增大与不良结局相关。
研究设计与样本
- 多中心队列研究,纳入18个欧洲中心的129例BAG3突变携带者(62%男性,年龄35.1±15.0岁)。
- 对截短型BAG3突变患者的心脏组织进行免疫组化分析BAG3定位。
主要发现
- 首次评估时57.4%患者有DCM,中位随访38个月(四分位距7-95个月)后68.4%有DCM。
- 初始表型阴性的患者中26.1%发展为DCM。
- 40岁以上个体末次评估时疾病外显率为80%。
- 男性DCM发病年龄有更早趋势(34.6±13.2岁 vs 40.7±12.2岁;p=0.053)。
- DCM患者不良心脏事件(死亡、左室辅助装置、心脏移植、持续性室性心律失常)年发生率为5.1%。
临床怎么用
- 对BAG3突变携带者,尤其40岁以上男性,应定期评估左室射血分数和左室舒张末内径以识别高风险患者。
- 合并DCM的BAG3突变患者需警惕进展性心力衰竭和不良心脏事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The BAG3 (BLC2-associated athanogene 3) gene codes for an antiapoptotic protein located on the sarcomere Z-disc. Mutations in BAG3 are associated with dilated cardiomyopathy (DCM), but only a small number of cases have been reported to date, and the natural history of BAG3 cardiomyopathy is poorly understood. OBJECTIVES: This study sought to describe the phenotype and prognosis of BAG3 mutations in a large multicenter DCM cohort. METHODS: The study cohort comprised 129 individuals with a BAG3 mutation (62% males, 35.1 ± 15.0 years of age) followed at 18 European centers. Localization of BAG3 in cardiac tissue was analyzed in patients with truncating BAG3 mutations using immunohistochemistry. RESULTS: At first evaluation, 57.4% of patients had DCM. After a median follow-up of 38 months (interquartile range: 7 to 95 months), 68.4% of patients had DCM and 26.1% who were initially phenotype-negative developed DCM. Disease penetrance in individuals >40 years of age was 80% at last evaluation, and there was a trend towards an earlier onset of DCM in men (age 34.6 ± 13.2 years vs. 40.7 ± 12.2 years; p = 0.053). The incidence of adverse cardiac events (death, left ventricular assist device, heart transplantation, and sustained ventricular arrhythmia) was 5.1% per year among individuals with DCM. Male sex, decreased left ventricular ejection fraction. and increased left ventricular end-diastolic diameter were associated with adverse cardiac events. Myocardial tissue from patients with a BAG3 mutation showed myofibril disarray and a relocation of BAG3 protein in the sarcomeric Z-disc. CONCLUSIONS: DCM caused by mutations in BAG3 is characterized by high penetrance in carriers >40 years of age and a high risk of progressive heart failure. Male sex, decreased left ventricular ejection fraction, and enlarged left ventricular end-diastolic diameter are associated with adverse outcomes in patients with BAG3 mutations.
引用
- Domínguez F, Cuenca S, Bilińska Z, et al. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations. J Am Coll Cardiol. 2018. PMID: 30442290. doi:10.1016/j.jacc.2018.08.2181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。